Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreationa…
$0.65-3.58%
报价 2026-11-06
市值
$275.8M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -66.1%
$0.65$1.92
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CGCCanopy Growth Corporation | $275.8M | -3.6% | – | 27.4% | – | – | – | |
| KMDAKamada Ltd. | $417.1M | +5.2% | – | 42.3% | 23.3x | 10.8x | – | |
| EMBCEmbecta Corp. | $350.7M | -2.2% | +4.3% | 59.9% | 3.3x | 5.8x | 1.8x | Cheap |
| SNDLSNDL Inc. | $346.4M | +2.5% | – | 19% | – | 8.8x | – | |
| ACBAurora Cannabis Inc. | $344.5M | +1.0% | – | -5.9% | – | – | – | |
| TLRYTilray Brands, Inc. | $326.5M | +3.9% | – | 30.1% | – | – | – | |
| EBSEmergent BioSolutions Inc. | $310.7M | +3.6% | -9.4% | 49.4% | – | – | 4.3x | |
| LFCRLifecore Biomedical, Inc. | $241.1M | -0.6% | +62.7% | 29.7% | – | – | – | |
| SIGASIGA Technologies, Inc. | $222.7M | +4.4% | -32.0% | – | – | – | – | |
| 同行中位数 | – | – | -2.6% | 30.1% | 13.3x | 8.8x | 3.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 CAD（非美元）| Metric | 2026-06-30 Q1 2027 | 2026-03-31 Q4 2026 | 2025-12-31 Q3 2026 | 2025-09-30 Q2 2026 | 2025-06-30 Q1 2026 | 2025-03-31 Q4 2025 | 2024-12-31 Q3 2025 | 2024-09-30 Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | CAD 81.2M | CAD 71.2M | CAD 102.3M | CAD 66.7M | CAD 72.1M | CAD 65M | CAD 74.8M | CAD 63M |
| Gross Margin | 27.4% | 11.6% | 28.8% | 32.8% | 25% | 16.2% | 32.2% | 34.7% |
| Operating Margin | -27.2% | -38.6% | -35.3% | -25.3% | -31.4% | -6.7% | -31.9% | -72.9% |
| Net Income | CAD -14.6M | CAD -157.1M | CAD -85.9M | CAD -1.6M | CAD -41.5M | CAD -220.8M | CAD -121.9M | CAD -128.3M |
| Diluted EPS | -0.03 | -0.4 | -0.25 | -0.01 | -0.22 | -1.43 | -1.11 | -1.48 |
| Operating Cash Flow | CAD -25M | CAD -18.3M | CAD -17.2M | CAD -18M | CAD -10.3M | CAD -33.2M | CAD -27M | CAD -53.9M |
研究材料
电话会纪要摘要
暂无纪要摘要。